Summary: This ADC product is comprised of an anti-CD33 monoclonal antibody (h2H12ec) conjugated via a Mc-VC linker to SGD-1882. The SGD-1882 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, SGD-1882 binds to DNA, causes DNA damage. https://www.creative-biolabs.com/adc/target-cd33-11.htm